Cancer Treatment Reviews
Volume 31, Issue 7 , Pages 555-570, November 2005

Radiation recall: A well recognized but neglected phenomenon

  • David Azria

      Affiliations

    • Department of Radiation Oncology, Val d’Aurelle-Paul Lamarque Cancer Institute, Montpellier, France
    • Tumor Immunotargeting and Antibody Engineering, EMI 0227, Montpellier, France
  • ,
  • Nicolas Magné

      Affiliations

    • Département de Radiothérapie, Institut Jules Bordet, 121 Boulevard de Waterloo, 1000 Brussels, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: + 32 2 541 3825; fax: + 32 2 538 7542.
  • ,
  • Abderrahim Zouhair

      Affiliations

    • Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
  • ,
  • Pierre Castadot

      Affiliations

    • Département de Radiothérapie, Institut Jules Bordet, 121 Boulevard de Waterloo, 1000 Brussels, Belgium
  • ,
  • Stéphane Culine

      Affiliations

    • Department of Medical Oncology, Val d’Aurelle-Paul Lamarque Cancer Institute, Montpellier, France
  • ,
  • Marc Ychou

      Affiliations

    • Department of Medical Oncology, Val d’Aurelle-Paul Lamarque Cancer Institute, Montpellier, France
  • ,
  • Roger Stupp

      Affiliations

    • Department of Medical Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
  • ,
  • Paul Van Houtte

      Affiliations

    • Département de Radiothérapie, Institut Jules Bordet, 121 Boulevard de Waterloo, 1000 Brussels, Belgium
  • ,
  • Jean-Bernard Dubois

      Affiliations

    • Department of Radiation Oncology, Val d’Aurelle-Paul Lamarque Cancer Institute, Montpellier, France
  • ,
  • Mahmut Ozsahin

      Affiliations

    • Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

published online 19 September 2005.

Summary 

Introduction

Radiation recall is an inflammatory skin reaction at a previously irradiated field subsequent to the administration of a variety of pharmacologic agents. Although skin has been the major site of radiation recall toxicity, instances involving other organ have been reported.

Materials and methods

Data for this review were identified by searches of Medline and Cancerlit. The search terms “radiation”, “recall”, and “toxicity” were used. References identified from within retrieved articles were also used. There was no limitation on year of publication and no abstract forms were included. Only articles published in English were taken into consideration.

Results

Idiosyncratic drug hypersensitivity phenomenon is a recent hypothesis which correlates best with the available facts at this moment. The phenomenon may occur days to years after radiotherapy has been completed. The majority of the drugs commonly used in cancer therapy have been involved in the radiation recall phenomenon. A mixed non-specific inflammatory infiltrate seems to be the common histopathologic criteria in previous published reports. Universally, corticosteroids or the use of non-steroidal anti-inflammatory agents, in conjunction with withdrawal of the offending agent, produce prompt improvement.

Conclusion

We propose to collect all future radiation recall phenomenon in a Rare Cancer Network database in order to augment our understanding of this rare reaction.

Keywords: Dermatitis recall phenomenon, Radiation, Chemotherapy, Side effects, Rare cancer network

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0305-7372(05)00126-X

doi:10.1016/j.ctrv.2005.07.008

Cancer Treatment Reviews
Volume 31, Issue 7 , Pages 555-570, November 2005